Literature DB >> 32224275

The role of eosinophils in chronic spontaneous urticaria.

Sabine Altrichter1, Stefan Frischbutter1, Jie Shen Fok2, Pavel Kolkhir3, Qingqing Jiao4, Per Stahl Skov5, Martin Metz1, Martin K Church1, Marcus Maurer6.   

Abstract

Chronic spontaneous urticaria (CSU) is considered to be primarily a mast cell-driven disease. However, recent evidence suggests that eosinophils may also have an axial role in symptomology. Histologic studies have demonstrated the presence of both eosinophils and eosinophil granules, indicative of activation, in CSU lesions. Although many allergic and inflammatory conditions are associated with a peripheral blood eosinophilia, the converse appears to be the case in CSU, with a peripheral blood eosinopenia being observed in many patients. Possible mechanisms include the depletion of blood eosinophils by recruitment into the skin during active disease and immunologic destruction in the blood. We also address in some detail the interactions between eosinophils and mast cells, particularly the cytokine cross-talk of these cells and mediator release possibly leading to clinical symptoms. Also, activation by eosinophil proteins of the coagulation pathway leads to the generation of thrombin and increased mast cell degranulation. Finally, treatments aimed at reducing eosinophil accumulation and activation, such as the anti-IL-5 antibodies mepolizumab, reslizumab, and benralizumab, have been reported to reduce CSU symptoms. Clearly, a new picture of an important role of eosinophils in the pathogenesis of CSU is emerging.
Copyright © 2020 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Urticaria chronic spontaneous urticaria; eosinophil; mast cell

Mesh:

Substances:

Year:  2020        PMID: 32224275     DOI: 10.1016/j.jaci.2020.03.005

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  12 in total

Review 1.  Urticaria.

Authors:  Pavel Kolkhir; Ana M Giménez-Arnau; Kanokvalai Kulthanan; Jonny Peter; Martin Metz; Marcus Maurer
Journal:  Nat Rev Dis Primers       Date:  2022-09-15       Impact factor: 65.038

2.  A fully human anti-c-Kit monoclonal antibody 2G4 inhibits proliferation and degranulation of human mast cells.

Authors:  Kwang-Hyeok Kim; Jin-Ock Kim; Sang Gyu Park
Journal:  Mol Cell Biochem       Date:  2022-09-15       Impact factor: 3.842

Review 3.  Pathophysiology, Diagnosis, and Management of Chronic Spontaneous Urticaria: A Literature Review.

Authors:  Benjamin Greiner; Savannah Nicks; Michael Adame; Jennifer McCracken
Journal:  Clin Rev Allergy Immunol       Date:  2022-09-01       Impact factor: 10.817

Review 4.  Controversies in Allergy: The Potential Role of Biologics as First-Line Therapy in Eosinophilic Disorders.

Authors:  Evan S Dellon; Dagmar Simon; Michael E Wechsler
Journal:  J Allergy Clin Immunol Pract       Date:  2022-02-12

5.  Childhood blood eosinophils and symptoms of allergic disorders: a cross-sectional study in Southern China.

Authors:  Xiangqing Hou; Wenting Luo; Hui Gan; Tianhao Chen; Baoqing Sun
Journal:  Ann Med       Date:  2022-12       Impact factor: 5.348

Review 6.  The Role of Crosstalk of Immune Cells in Pathogenesis of Chronic Spontaneous Urticaria.

Authors:  Bingjing Zhou; Jie Li; Runqiu Liu; Lei Zhu; Cong Peng
Journal:  Front Immunol       Date:  2022-05-31       Impact factor: 8.786

7.  Eosinophils and associated parameters in different types of skin diseases related to elevated eosinophil levels.

Authors:  Tong Wu; Luyan Tang; Yang Feng; Yanjing Jia; Fei Li
Journal:  Ann Transl Med       Date:  2022-01

Review 8.  Monoclonal Antibodies in Treating Chronic Spontaneous Urticaria: New Drugs for an Old Disease.

Authors:  Sara Manti; Alessandro Giallongo; Maria Papale; Giuseppe Fabio Parisi; Salvatore Leonardi
Journal:  J Clin Med       Date:  2022-07-30       Impact factor: 4.964

Review 9.  Eosinophils in skin diseases.

Authors:  Susanne Radonjic-Hoesli; Marie-Charlotte Brüggen; Laurence Feldmeyer; Hans-Uwe Simon; Dagmar Simon
Journal:  Semin Immunopathol       Date:  2021-06-07       Impact factor: 9.623

Review 10.  Differences and Similarities in the Mechanisms and Clinical Expression of Bradykinin-Mediated vs. Mast Cell-Mediated Angioedema.

Authors:  Marcus Maurer; Markus Magerl
Journal:  Clin Rev Allergy Immunol       Date:  2021-02-03       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.